By reducing the number of LDL receptors (LDLR) on the surface of liver cells, PCSK9 leads to the accumulation of LDL-C, increasing the risk of CVDs
According to Dr Ambrish Mithal, chairman and head of endocrinology and diabetes at Max Super Speciality Hospital, Wegovy primarily targets GLP-1 receptors, while Mounjaro acts on both GLP-1 and GIP receptors, offering dual action
Body weight dropped by 7.9% over this time frame versus 1.6% in placebo comparators
however, it peaks at 30 minutes and decreases after 60 minutes, generally lasting only three to four hours
GLP-1s have a negative reputation around them so people dont admit they are taking them
If it seems like your diet is high in processed foods, caffeine, dairy, fatty cuts of meat and sugary sweets, then your problem could be linked to your diet